TMEM176B Polyclonal antibody
TMEM176B Polyclonal Antibody for WB, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human and More (1)
Applications
WB, ELISA and More (1)
Conjugate
Unconjugated
验证数据展示
经过测试的应用
Positive WB detected in | A549 cells, human placenta tissue |
推荐稀释比
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:200-1:1000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
WB | See 1 publications below |
IF | See 1 publications below |
产品信息
The immunogen of 19825-1-AP is TMEM176B Fusion Protein expressed in E. coli.
Tested Applications | WB, ELISA Application Description |
Cited Applications | WB, IF |
Tested Reactivity | human |
Cited Reactivity | human, mouse |
Immunogen | TMEM176B fusion protein Ag13918 种属同源性预测 |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Full Name | transmembrane protein 176B |
Synonyms | LR8, Protein LR8, TMEM176B, transmembrane protein 176B |
Calculated Molecular Weight | 270 aa, 29 kDa |
Observed Molecular Weight | 31 kDa, 23 kDa |
GenBank Accession Number | BC004358 |
Gene Symbol | TMEM176B |
Gene ID (NCBI) | 28959 |
RRID | AB_10638313 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
UNIPROT ID | Q3YBM2 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
实验方案
Product Specific Protocols | |
---|---|
WB protocol for TMEM176B antibody 19825-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
Int J Biol Macromol Formulating a TMEM176B blocker in chitosan nanoparticles uncouples its paradoxical roles in innate and adaptive antitumoral immunity | ||
Front Genet Comprehensive Analysis of Expression and Prognostic Value of MS4As in Glioma. | ||
Cancer Cell Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation. |